Self help organization’s advice on myalgic encephalomyelitis
…is worth emphasising that the quote that illustrates this came from Nursing Standard and not from a magazine for patients. The British organisations have long been unhappy with the way…
…is worth emphasising that the quote that illustrates this came from Nursing Standard and not from a magazine for patients. The British organisations have long been unhappy with the way…
…Techniques: Perrin Technique, Chelation, Coffee Enemas Immune Support: Transfer Factor, Live Cell Therapy Global Support: Hydrotherapy, Hyperbaric oxygen, Ayurveda Further Reading National Center for Complementary and Alternative Medicine http://nccam.nih.gov/…
…anytime with viewing later. An additional 100+ individuals did not attend live and are interested in the conference recording which we expect will be available in early to mid-September. Our…
Abstract: 250,000 people live with Myalgic Encephalitis (ME) in the UK, this compares to 100,000 living with Multiple Sclerosis. In 2019, a survey by MEAction of 1906 people with ME,…
…a service largely depends on where you live—and in many countries action seems to be limited to guidance and monitoring. Read the rest of this article HERE. Source: Baraniuk C….
…function. Importantly, it has recently been reported that NTX restores impaired TRPM3 function in NK cells of ME/CFS patients. Methods: Live cell immunofluorescent imaging was used to measure TRPM3-dependent Ca2+…
…stress, and sleep disturbance commonly triggered symptoms. A third (32%) reported they were unable to live alone without any assistance at six weeks from start of illness. 16.9% reported being…
…David Tuller’s spring fundraiser is now live! Tuller has been tireless in his battle against the GET/CBT ideological onslaught! He has much more work to do and he needs our…
…by phenomenology which yielded three central themes: The active and meaningful life I used to live; gradually developing unhomeliness and feeling pushed toward the edge; and left abandoned on the…
…JA. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc. 2022 May 1;43(3):187-193. doi: 10.2500/aap.2022.43.220018. PMID: 35524358. https://pubmed.ncbi.nlm.nih.gov/35524358/ https://www.ingentaconnect.com/content/ocean/aap/2022/00000043/00000003/art00003;jsessionid=pp9ea7gev7kv.x-ic-live-01# (Full text…